Beyond the laboratory: clinical implications for statin pleiotropy.
about
The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesEzetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.Anticipating the evolution of clinical cholesterol guidelines: implications of recent statin intervention trials.Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome.Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia.Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator.Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes.Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?Effect of statin pretreatment on myocardial perfusion in patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.Monocytic adhesion molecule expression and monocyte-endothelial cell dysfunction are increased in patients with peripheral vascular disease versus patients with abdominal aortic aneurysmsStatins and acute lung injury: Holy Grail or the next to fail?Hemodynamic effects of peri-operative statin therapy in on-pump cardiac surgery patientsOsteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation.Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathwayVinpocetine attenuates lipid accumulation and atherosclerosis formation.Advances in hemorrhagic stroke therapy: conventional and novel approaches.Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.Effects of probiotic bacteria, isoflavones and simvastatin on lipid profile and atherosclerosis in cholesterol-fed rabbits: a randomized double-blind study.Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation.Translocation of bacterial NOD2 agonist and its link with inflammation.Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study.Effects of preoperative statin use on perioperative outcomes of carotid endarterectomy.Statins and amyotrophic lateral sclerosis--the level of evidence for an association.An old friend in a new light: the role of osteocalcin in energy metabolism.Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway.Statin therapy might be beneficial for patients with ankylosing spondylitis.Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-beta.Active cytomegalovirus replication in patients with coronary disease.3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice.Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction.The effects of atorvastatin on the prevention of osteoporosis and dyslipidemia in the high-fat-fed ovariectomized rats.Association of statin use and risk for severe headache or migraine by serum vitamin D status: a cross-sectional population-based study.The chequered history of the antiphospholipid syndrome.High-dose atorvastatin ameliorates the uterine microenvironment in streptozotocin-induced diabetic rats.Efficacy of simvastatin in reducing postoperative adhesions after thyroidectomy: an experimental study.
P2860
Q24796000-F0A408BD-AD28-4C90-8EAD-D51149DB878DQ28388335-972C3555-6F3D-402C-8716-AC8376F65583Q30547579-23C9671C-A479-4B72-B46D-403CD4DCB4CBQ33508676-044629DE-3C9D-45CF-B277-16D3D84D6CBAQ33678607-13C5DFDD-7F15-418C-8130-E146C000397AQ33847777-6CE8ADB8-D7E5-44E7-96A9-971C77B0DC64Q33892777-2CF4E502-9E13-4968-90D3-3CA1159A74B1Q33976397-E1AA7D09-F6A6-4A82-BC4B-F81F9F0145BEQ34128364-41678AE7-AE2D-4035-98DF-4360D1854D90Q34255430-51416844-B5E6-472C-8B1C-A29ED49E8F73Q34871872-0C5540AB-1828-4975-BF83-03CFA44BF935Q35007498-C3BDEDB6-A2CC-4983-AE00-B3064DEECAF7Q35636929-3431A62F-0C76-4EE0-A526-1D682E69BB8EQ35897682-987F9528-280B-4F86-94DE-07BBDA53B47FQ36100702-7C274193-DE00-456B-A7B2-56B2F97631C9Q36162995-5FFC20E6-1EAD-4BD1-B0A4-4042723D1D8FQ36536154-0598A4CF-AFE8-4EFA-9DA8-EB5B065EC536Q36580738-BE4AB54D-422B-44A4-A8A9-AD8A55D73740Q36928884-5CE1A853-38B5-43F7-B7F1-21FCF0173A60Q36944012-FDF1D776-F911-4EA7-8B0F-A89C37925F00Q36986116-93F582E0-807C-458A-965C-6B4C286601E6Q37067559-5ACAF662-25AF-4F85-834B-CA31125257A6Q37237168-170D9018-11D5-4F13-91CE-3458E565F303Q37360336-B9BF74DF-921F-4602-9BA4-F2733E619B61Q37367995-198C35A4-6E9C-41D4-9CB0-B855ABC24D34Q37599656-B8F02492-9D13-4758-9BA2-48E77963148AQ37636347-F2E5B5B3-2144-4A7D-92F0-DA8CE736DCBFQ37942705-F24AC1DA-3DB5-4217-90AF-A811B4542102Q37993779-C6C5C8F9-60D2-453E-B806-E3E96670C05CQ40645430-62C04D95-C14D-44C1-8D97-29864355DF10Q42956017-9EF8E066-CA4F-4D99-916D-A720B7029DCFQ43123382-448BF7AE-8CED-4493-822F-329A62B33A6EQ43415680-F0C8C956-1A45-4253-B8DD-EB9DFA08837CQ45854741-47BF0F68-C40C-4B0E-8CAF-6508D51C3C88Q46886146-DA2807F3-929A-4AF2-B771-8E0E9D58CC10Q47729932-252ABCDD-D805-4390-8702-2287E9664757Q47786650-5E2402B2-8BFF-4AA9-B20D-E5480A327E83Q48081474-EA7B78E8-E25F-4E73-9A2B-B09089D882C1Q51130233-393A7EC6-BDAC-4278-9F14-6C1D6FBBE7CEQ53010480-7DF36E47-AC09-4C53-B104-9F3FD01B851A
P2860
Beyond the laboratory: clinical implications for statin pleiotropy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Beyond the laboratory: clinical implications for statin pleiotropy.
@ast
Beyond the laboratory: clinical implications for statin pleiotropy.
@en
type
label
Beyond the laboratory: clinical implications for statin pleiotropy.
@ast
Beyond the laboratory: clinical implications for statin pleiotropy.
@en
prefLabel
Beyond the laboratory: clinical implications for statin pleiotropy.
@ast
Beyond the laboratory: clinical implications for statin pleiotropy.
@en
P1433
P1476
Beyond the laboratory: clinical implications for statin pleiotropy.
@en
P2093
John E Deanfield
Julian P J Halcox
P304
P356
10.1161/01.CIR.0000129500.29229.92
P407
P433
21 Suppl 1
P577
2004-06-01T00:00:00Z